title: Fenofibrate lowers plasma triglycerides and increases LDL particle diameter in subjects with type 2 diabetes.
authors.forename: Juha
authors.initials: J
authors.lastname: Vakkilainen
authors.forename: George
authors.initials: G
authors.lastname: Steiner
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Ansquer
authors.forename: Hëlina
authors.initials: H
authors.lastname: Perttunen-Nio
authors.forename: Marja-Riitta
authors.initials: MR
authors.lastname: Taskinen
mesh_terms: D008078:Cholesterol, LDL / Q000097:blood*; D003327:Coronary Disease / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D003925:Diabetic Angiopathies / Q000517:prevention & control; D011345:Fenofibrate / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008077:Lipoproteins, LDL / Q000097:blood*; D010919:Placebos; D014280:Triglycerides / Q000097:blood*
chemical_list: D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D008077:Lipoproteins, LDL; D010919:Placebos; D014280:Triglycerides; D011345:Fenofibrate